Ami M. Kabadi

3.9k citations

15 papers · 2.9k indexed · 2 hit papers · h-index 12

Molecular Biology top 2%
Genetics top 5%
Aging top 1%
Business and International Management top 1%
Plant Science top 10%

Co-authors: Charles A. Gersbach Pratiksha I. Thakore David G. Ousterout Timothy E. Reddy Gregory E. Crawford Kam W. Leong Pablo Pérez‐Piñera Lingyun Song
Topics: CRISPR and Genetic Engineering (12 papers)Pluripotent Stem Cells Research (5 papers)Virus-based gene therapy research (3 papers)
Cited by: Aging Business and International Management Molecular Biology
Journals: Nucleic Acids Research Nature Communications Nature Methods
Partner nations: United States Saudi Arabia Canada

In The Last Decade

Ami M. Kabadi

14 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA-guided gene activation by CRISPR-Cas9–based transcription factors

2013 1.0k citations Pablo Pérez‐Piñera, D. Dewran Koçak et al. Nature Methods profile →
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

2015 690 citations Pratiksha I. Thakore, Anthony D’Ippolito et al. Nature Methods profile →

Peers

Countries citing papers authored by Ami M. Kabadi

Since Specialization

Citations

This map shows the geographic impact of Ami M. Kabadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami M. Kabadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami M. Kabadi more than expected).

Fields of papers citing papers by Ami M. Kabadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ami M. Kabadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami M. Kabadi. The network helps show where Ami M. Kabadi may publish in the future.

Co-authorship network of co-authors of Ami M. Kabadi

This figure shows the co-authorship network connecting the top 25 collaborators of Ami M. Kabadi. A scholar is included among the top collaborators of Ami M. Kabadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ami M. Kabadi. Ami M. Kabadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities 2023 ·Current Opinion in Biomedical Engineering ·Ami M. Kabadi,Maria Katherine Mejía‐Guerra,John D. Graef,Sohrab Khan,Eric M. Walton,Xinzhu Wang,Charles A. Gersbach,Rachael A. Potter	7
2	Epigenome editing of the CFTR-locus for treatment of cystic fibrosis 2021 ·Journal of Cystic Fibrosis ·Ami M. Kabadi,(unknown),(unknown),Rhianna E. Lee,Ian C. McDowell,Nirav N. Shah,Lauren Drowley,Scott H. Randell,Timothy E. Reddy	12
3	Applications of Functional Genomics for Drug Discovery 2020 ·SLAS DISCOVERY ·Ami M. Kabadi,Eoin McDonnell,Christopher L. Frank,Lauren Drowley	6
4	Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies 2017 ·Nucleic Acids Research ·(unknown),Lingyun Song,Ami M. Kabadi,Jennifer B. Kwon,Lee Edsall,Melanie Ehrlich,Koji Tsumagari,Charles A. Gersbach,Gregory E. Crawford,Raluca Gordân	24
5	Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy 2015 ·Nature Communications ·David G. Ousterout,Ami M. Kabadi,Pratiksha I. Thakore,William H. Majoros,Timothy E. Reddy,Charles A. Gersbach	338
6	Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elementsbreakdown → 2015 ·Nature Methods ·Pratiksha I. Thakore,Anthony D’Ippolito,Lingyun Song,Alexias Safi,(unknown),Ami M. Kabadi,Timothy E. Reddy,Gregory E. Crawford,Charles A. Gersbach	690
7	485. Targeted Epigenome Editing by CRISPR/Cas9-Based Repressors for Silencing of Distal Regulatory Elements 2015 ·Molecular Therapy ·Pratiksha I. Thakore,Anthony D’Ippolito,Lingyun Song,Alexias Safi,(unknown),Ami M. Kabadi,Peggy J. Bledsoe,Timothy E. Reddy,Gregory E. Crawford,Charles A. Gersbach	0
8	Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector 2014 ·Nucleic Acids Research ·Ami M. Kabadi,David G. Ousterout,Isaac B. Hilton,Charles A. Gersbach	264
9	Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression 2014 ·Methods ·Ami M. Kabadi,Charles A. Gersbach	36
10	A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification 2014 ·Stem Cell Reports ·Syandan Chakraborty,HaYeun Ji,Ami M. Kabadi,Charles A. Gersbach,Nicolas Christoforou,Kam W. Leong	170
11	Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases 2014 ·Molecular Therapy ·David G. Ousterout,Ami M. Kabadi,Pratiksha I. Thakore,Pablo Pérez‐Piñera,Matthew T. Brown,William H. Majoros,Timothy E. Reddy,Charles A. Gersbach	85
12	Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 2014 ·ACS Synthetic Biology ·Ami M. Kabadi,Pratiksha I. Thakore,Christopher M. Vockley,David G. Ousterout,(unknown),Farshid Guilak,Timothy E. Reddy,Charles A. Gersbach	34
13	Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients 2013 ·Molecular Therapy ·David G. Ousterout,Pablo Pérez‐Piñera,Pratiksha I. Thakore,Ami M. Kabadi,Matthew T. Brown,Xiaoxia Qin,Olivier Fédrigo,Vincent Mouly,Jacques P. Tremblay,Charles A. Gersbach	139
14	RNA-guided gene activation by CRISPR-Cas9–based transcription factorsbreakdown → 2013 ·Nature Methods ·Pablo Pérez‐Piñera,D. Dewran Koçak,Christopher M. Vockley,Andrew F. Adler,Ami M. Kabadi,Lauren R. Polstein,Pratiksha I. Thakore,Katherine A. Glass,David G. Ousterout,Kam W. Leong,Farshid Guilak,Gregory E. Crawford,Timothy E. Reddy,Charles A. Gersbach	1005
15	Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B 2008 ·Bioorganic & Medicinal Chemistry Letters ·David M. Gooden,Dawn M. Z. Schmidt,Julie A. Pollock,Ami M. Kabadi,Dewey G. McCafferty	64

About Ami M. Kabadi

Ami M. Kabadi is a scholar working on Aging, Business and International Management and Molecular Biology, having authored 15 papers that have together received 2.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (12 papers), Pluripotent Stem Cells Research (5 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Aging (226 citations), Business and International Management (201 citations) and Molecular Biology (2.7k citations). Ami M. Kabadi has collaborated with scholars based in United States, Saudi Arabia and Canada. Frequent co-authors include Charles A. Gersbach, Pratiksha I. Thakore, David G. Ousterout, Timothy E. Reddy, Gregory E. Crawford, Kam W. Leong, Pablo Pérez‐Piñera, Lingyun Song, Anthony D’Ippolito and Alexias Safi. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Nature Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact